The revised manuscript entitled “Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations” by Naucler, et al. has been submitted by the authors as a replacement for the originally published version of the manuscript. Following publication, the authors became aware of several discrepancies in the originally designated crossover dates between vaccine products in certain counties from the actual crossover dates. After an extensive effort to more clearly delineate vaccine crossover dates, the authors have reanalyzed their data and have submitted a corrected manuscript. This version of the manuscript has been reviewed by members of the Editorial Board and is being republished after retraction of the original version of the manuscript.
. 2018 Oct 9;68(3):534. doi: 10.1093/cid/ciy857
Editor’s Note
Issue date 2019 Feb 1.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMCID: PMC6336903 PMID: 30304380
See "Erratum" on page 175.
This corrects the article "Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations" in volume 65 on page 1780.